This Brain Computer Startup Beat Neuralink to FDA Trials

The implanted device is called Stentrode, and it’s smaller than a matchstick. It is installed in the brain of paralyzed patients and helps them control digital devices like computer cursors via thought. This is achieved via a small wire connected to a second implant in the chest that has a transmitter that sends signals to a computer. Synchron’s trial will consist of six patients, and if successful will advance the implant to the next step in the lengthy approval process. It’s estimated that the Synchron device could be on the market in 3-5 years.